SL Science Holding Limited SLBT
1.22 USD -0.05 (-3.94%)
At closeNov 3, 2026, 4:00 PM EST
1.22 0.00 0.00%
After hours · Nov 3, 4:00 PM ET
1.22 Day range 1.30
1.02 52-week range 14.50
- YTD
- -88.44%
- 1 year
- -88.26%
- Market cap
- 684.13M
- Revenue (ttm)
- 3.27M
- Profit margin
- -72.46%
- Shares out
- 560.76M
- YTD return
- -88.44%
- 1-year return
- -88.26%
- Volume
- 7.45K
- Avg volume
- 66.65K
- Open
- 1.27
- Previous close
- 1.27
- Day's range
- 1.22 – 1.30
- 52-week range
- 1.02 – 14.50
2Y -8.77 (-87.52%)
Key statistics
- Enterprise value
- 4.03M
- PEG ratio
- 0.00
- Price / sales
- 313.81
- Price / book
- 1.42
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- -7.60%
- Free cash flow
- 0
- Total cash
- 3.37M
- Total debt
- 305.67K
- Return on equity
- 0.00%
- Short % of float
- 0.01%
- 50-day average
- 2.59
- 200-day average
- 7.18
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
SLBT Revenue — quarterly 2.20M
SLBT Net income — quarterly -5.13M
SLBT EPS — quarterly 0.099
About SL Science Holding Limited
SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company's products include SL bio's milk-derived exosome essence, SL bio's tangerine-derived extract, and the MilkExo concentrate series. It also offers research services in armed T-cells, gamma delta T- cells, citrus reticulata (tangerine) extract, and milk-derived exosomes. SL Science Holding Limited was formerly known as SL BIO Co., Ltd. and changed its name to SL Science Holding Limited in June 2026. The company is based in Taipei, Taiwan.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- Taiwan
- Website
- sl-bio.com
News
SL Science Holding H1 Sales $1.387M Up From $1.129M YoY 
SL Science Holding Limited Reports First Half 2026 Financial Results 
12 Health Care Stocks Moving In Monday's After-Market Session 
Kodiak Sciences, AMC Entertainment, Agenus And Other Big Stocks Moving Higher On Monday 
SL Science Presents Preclinical Data at the 85th Annual Meeting of the Japanese Cancer Association Showing γδ T Cells Target Chemotherapy-Resistant Glioblastoma 
SL Science: A $1.15 Billion Valuation Built On Preclinical Promises 
12 Health Care Stocks Moving In Thursday's Intraday Session - 12 Health Care Stocks Moving In Thursday's Pre-Market Session
NetApp, Hewlett Packard Enterprise And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session 
Why Snowflake Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket
Your note
Sign in to keep a note on SLBT — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Geode Capital Management, LLC | 0.03% | 193,404 | 353.93K | Jun 29, 2026 |
| L1 Global Manager Pty Ltd | 0.03% | 150,000 | 274.50K | Jun 29, 2026 |
| RiverNorth Capital Management, LLC | 0.02% | 130,000 | 237.90K | Jun 29, 2026 |
| SkyView Investment Advisors, LLC | 0.01% | 42,042 | 76.94K | Jun 29, 2026 |
| Lynx Capital Group Ltd /adv | 0.00% | 17,096 | 31.29K | Jun 29, 2026 |
| UBS Group AG | 0.00% | 12,515 | 22.90K | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 0.06% | 338,215 | 618.93K | Jul 30, 2026 |